How has Agilon Health's cash and cash equivalents, end of period changed year-over-year?

Agilon Health's cash and cash equivalents, end of period increased by 52.6% year-over-year, from $138.62M to $211.57M.

What is the long-term trend for Agilon Health's cash and cash equivalents, end of period?

Over 3 years (2022 to 2025), Agilon Health's cash and cash equivalents, end of period has grown at a -30.1% compound annual growth rate (CAGR), from $507.68M to $173.71M.

Agilon Health AGL Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Arthur J. GallagherAJG

$8.48B-61.9%

3MMMM

$3.73B-41.1%

Phillips 66PSX

$5.15B+246%

eBayEBAY

$4.23B+1.9%

American Financial GroupAFG

$1.35B+6.0%

Erie Indemnity CompanyERIE

$268.62M+3.2%

Other financials

Income statement

See full

Revenue$1.4B-7.3%

Operating income$4.0M+118%

Net income$48.9M+304%

EPS (diluted)$2.94+303%

Balance sheet

See full

Cash & equivalents$211.6M+52.6%

Total debt$33.4M-20.5%

Total equity$181.4M-63.7%

Total assets$1.5B-22.1%

Cash flow

See full

Operating cash flow$23.7M+174%

CapEx$3.1M-19.4%

Free cash flow$20.6M+158%

Valuation

See full

Market cap$1.78B-92.6%

Enterprise value$1.61B-103%

P/S0.3×-3.8×

Profitability

See full

Operating margin-7.5%+6.5pp

Net margin-6.1%+6.3pp

FCF margin-1.1%—

Returns & leverage

See full

Return on equity-104%-291pp

Debt / equity0.2×+0.1×

Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agilon Health's cash and cash equivalents, end of period?: Agilon Health (AGL) reported cash and cash equivalents, end of period of $211.57M in Q1 2026.
How has Agilon Health's cash and cash equivalents, end of period changed year-over-year?: Agilon Health's cash and cash equivalents, end of period increased by 52.6% year-over-year, from $138.62M to $211.57M.
What is the long-term trend for Agilon Health's cash and cash equivalents, end of period?: Over 3 years (2022 to 2025), Agilon Health's cash and cash equivalents, end of period has grown at a -30.1% compound annual growth rate (CAGR), from $507.68M to $173.71M.